Related Articles |
Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia.
Cardiol Clin. 2018 May;36(2):277-285
Authors: Benes LB, Bassi NS, Kalot MA, Davidson MH
Abstract
Omega-3 fatty acids have shown modest benefit in certain subgroups at higher cardiovascular risk. Ongoing trials are investigating cardiovascular event rate reduction with newer, more efficacious formulations with a focus on these higher risk patients. This article focuses on the previously demonstrated benefits of omega-3 fatty acid therapies, currently available formulations, and their current and future role in reducing cardiovascular risk.
PMID: 29609757 [PubMed - in process]